Delivery Order SPE2DR25D9628-SPE2DR26FBTEN
- Not listed
- The Defense Logistics Agency awarded a $24,937.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra 30 mg/mL syringes. The delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under...
- The Defense Logistics Agency (DLA) awarded a $14,962.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The award, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was selected as...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,468.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for FASENRA 30 mg/ml syringes. The contract, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical...
- The Defense Logistics Agency has awarded a delivery order valued at $9,774.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of FASENRA 30 mg/ml syringes. DMS Pharmaceutical Group Inc. is a critical supplier within the federal pharmaceutical supply chain and has been registered in the System for Award Management since 2001. This delivery order was issued without a set-aside designation, reflecting the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,550.00 by the Defense Logistics Agency (DLA) on September 12, 2025. The delivery order, which is scheduled for completion by October 3, 2025, covers the supply of FASENRA Pen 30 mg/mL, a prescription pharmaceutical product, with performance to take place in Conshohocken, Pennsylvania. This award was made without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was awarded a delivery order valued at $2,275.00 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Fasenra Pen 30 mg/ml. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, with performance taking place in Conshohocken, Pennsylvania. The award was made without a set-aside designation, allowing the vendor to compete on an unrestricted basis in...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,443.50 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the drug Fasenra Pen 30 mg/mL. This delivery order was issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. Through this IDC vehicle, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical items...
- The Defense Logistics Agency awarded a delivery order valued at $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and was executed on July 22, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Fasenra 30 mg/ml syringes, and is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that runs through December 31, 2025. This IDC, under the SPE2DB program, allows the DLA to issue...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,443.50 on July 22, 2025, for the supply of Fasenra 30 mg/mL syringes. The contract, which has no set-aside designation, is set to be completed by July 23, 2025, and will be performed at the vendor's Park Ridge location. This delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and...
- SPE2DR25D9628Indefinite Delivery Contract
- SPE2DR25D9628-SPE2DR26FBTENDelivery Order
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $4,987.52 to DMS Pharmaceutical Group Inc. for Fasenra Pen 30mg/ml, an injectable pharmaceutical product used in respiratory and immunological treatments. This delivery order, awarded on December 2, 2025, with an ultimate completion date of the same day, carries no set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the prime contractor with no identified subcontractors on this award. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition vehicle designed to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/1/25 |